Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Pediatric Studies Characteristics - Detail
FDA Home
Pediatrics
Pediatric Studies Characteristics
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Approval Date:
06/05/2008
Trade Name:
Zetia and Vytorin
Generic or Proper Name (*):
ezetimibe and ezetimibe/ simvastatin
Indications Studied:
Heterozygous familial hypercholesterolemia as an adjunct to diet
Therapeutic Category:
Antilipemic
Ages Studied:
10-17 years
Study #:
1
Study Type:
Efficacy/Safety
Study Design:
Single-Blind/Active Control/Parallel Group
No Patients:
246
No Centers:
47
No Countries:
2
BPCA(B), PREA(P):
B, P
Asian:
9
Black:
4
Other:
32
White:
203
Native Hawaiian or Pacific Islander:
0
American Indian/Alaska Native:
0
Hispanic/Latino:
0
Non-Hispanic/Non Latino:
0
-
-